Root‐cause analyses of missed opportunities for the diagnosis of colorectal cancer in patients with inflammatory bowel disease

Colonoscopic surveillance in patients with inflammatory bowel disease (IBD) leads to earlier detection of colorectal cancer (CRC) and reduces CRC‐associated mortality. However, it is limited by poor adherence in practice.

[1]  T. Ahmad,et al.  Incidence and prevalence of inflammatory bowel disease in Devon, UK , 2020, Frontline Gastroenterology.

[2]  M. Vatn,et al.  Risk of colorectal cancer in a population-based study 20 years after diagnosis of ulcerative colitis: results from the IBSEN study , 2020, BMJ open gastroenterology.

[3]  J. Fichna,et al.  Biomarkers for early detection of colitis-associated colorectal cancer - current concepts, future trends. , 2020, Current drug targets.

[4]  H. Sørensen,et al.  Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study , 2020, The Lancet.

[5]  R. Valori,et al.  Causes of Post-colonoscopy Colorectal Cancers Based on World Endoscopy Organization System of Analysis. , 2020, Gastroenterology.

[6]  J. Gisbert,et al.  Clinical characteristics, associated malignancies and management of primary sclerosing cholangitis in inflammatory bowel disease patients: A multicenter retrospective cohort study. , 2019, Journal of Crohn's & colitis.

[7]  M. Parkes,et al.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults , 2019, Gut.

[8]  Kristin E. Burke,et al.  Interval Colorectal Cancer in Inflammatory Bowel Disease: The Role of Guideline Adherence , 2019, Digestive Diseases and Sciences.

[9]  G. Meijer,et al.  World Endoscopy Organization Consensus Statements on Post-Colonoscopy and Post-Imaging Colorectal Cancer. , 2018, Gastroenterology.

[10]  C. Bernstein,et al.  Consecutive negative findings on colonoscopy during surveillance predict a low risk of advanced neoplasia in patients with inflammatory bowel disease with long-standing colitis: results of a 15-year multicentre, multinational cohort study , 2018, Gut.

[11]  S. Bonovas,et al.  Systematic review with network meta‐analysis: comparative assessment of tofacitinib and biological therapies for moderate‐to‐severe ulcerative colitis , 2018, Alimentary pharmacology & therapeutics.

[12]  R. Hultcrantz,et al.  Rates and characteristics of postcolonoscopy colorectal cancer in the Swedish IBD population: what are the differences from a non-IBD population? , 2017, Gut.

[13]  H. D. de Koning,et al.  Personalizing colonoscopy screening for elderly individuals based on screening history, cancer risk, and comorbidity status could increase cost effectiveness. , 2015, Gastroenterology.

[14]  A. Hart,et al.  Low-Grade Dysplasia in Ulcerative Colitis: Risk Factors for Developing High-Grade Dysplasia or Colorectal Cancer , 2015, The American Journal of Gastroenterology.

[15]  A. Hart,et al.  Forty-Year Analysis of Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis: An Updated Overview , 2015, The American Journal of Gastroenterology.

[16]  W. Selby,et al.  Long-term follow-up reveals low incidence of colorectal cancer, but frequent need for resection, among Australian patients with inflammatory bowel disease. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[17]  A. Amiot,et al.  European evidence based consensus for endoscopy in inflammatory bowel disease. , 2013, Journal of Crohn's & colitis.

[18]  E. Horváth-Puhó,et al.  Cancer Risk in Inflammatory Bowel Disease According to Patient Phenotype and Treatment: A Danish Population-Based Cohort Study , 2013, The American Journal of Gastroenterology.

[19]  M. Sim,et al.  AJCC Cancer Staging Manual 7th edition criteria for colon cancer: do the complex modifications improve prognostic assessment? , 2013, Journal of the American College of Surgeons.

[20]  F. Carrat,et al.  Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. , 2013, Gastroenterology.

[21]  E. Horváth-Puhó,et al.  Five-Year Mortality in Colorectal Cancer Patients with Ulcerative Colitis or Crohn's Disease: A Nationwide Population-based Cohort Study , 2013, Inflammatory bowel diseases.

[22]  Gary King,et al.  MatchIt: Nonparametric Preprocessing for Parametric Causal Inference , 2011 .

[23]  F. Carrat,et al.  Low prevalence of colonoscopic surveillance of inflammatory bowel disease patients with longstanding extensive colitis: a clinical practice survey nested in the CESAME cohort , 2011, Alimentary pharmacology & therapeutics.

[24]  S. Hutfless,et al.  Prevalence of colorectal cancer surveillance for ulcerative colitis in an integrated health care delivery system. , 2010, Gastroenterology.

[25]  M. Goel,et al.  Understanding survival analysis: Kaplan-Meier estimate , 2010, International journal of Ayurveda research.

[26]  R. Rosenfeld,et al.  Authority , 2010, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[27]  R. Steele,et al.  Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002) , 2010, Gut.

[28]  D. Hommes,et al.  Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease , 2009, British Journal of Cancer.

[29]  J. Mate,et al.  Meta‐analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis , 2009, Alimentary pharmacology & therapeutics.

[30]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[31]  P. Pronovost,et al.  Effectiveness and efficiency of root cause analysis in medicine. , 2008, JAMA.

[32]  J. Satsangi,et al.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. , 2005, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[33]  P. Munkholm,et al.  Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[34]  Yunni-Yi Chen,et al.  Gross Versus Microscopic Pancolitis and the Occurrence of Neoplasia in Ulcerative Colitis , 2003, Inflammatory bowel diseases.

[35]  K. Abrams,et al.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis , 2001, Gut.

[36]  J. Carroll.  Organizational Learning Activities in High‐hazard Industries: The Logics Underlying Self‐Analysis , 1998 .

[37]  R. Haggitt,et al.  Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. , 1993, Gastroenterology.

[38]  M. F. William A. Bye B. Com,et al.  Strategies for Detecting Colorectal Cancer in Patients with Inflammatory Bowel Disease: A Cochrane Systematic Review and Meta-Analysis , 2018, The American Journal of Gastroenterology.

[39]  M. Picco.  Prevalence of Colorectal Cancer Surveillance for Ulcerative Colitis in an Integrated Health Care Delivery System , 2011 .

[40]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.